(Q73481578)

English

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study

scientific article published on 01 April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma. A North Thames Ovary Group Study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H E Lambert

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

G J Rustin

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W M Gregory

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A E Nelstrop

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 April 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

327-333

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

randomized experiment

0 references

The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsidered

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on Gynaecological Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with advanced ovarian cancers treated with intermittent administration of combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008256431090

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008256431090

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9209661%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73481578&oldid=1741869459"